Jun 2026 (Q2 FY26) — Aug 6, 2026
Unusual Machines Q2 FY26 — Strong Revenue Growth and Reduced EBITDA Loss
Read the full callUnusual Machines (UMAC) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Unusual Machines earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 16.7 | +687.3% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -46.9 | +291.7 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -7.8 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$16.4 +0.55% · +$0.09
Performance +32.9% 1Y
1Y: $12.34 on 17 Oct 2025 → $16.4. High $34.06 (14 Aug 2026), low $7.76 (20 Nov 2025).
- Previous close
- $16.31
- 52-week range
- $7.76 – $34.06
- One year
- +28.53%
Overview
- Symbol
- UMAC
- Sector
- Information Technology
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Unusual Machines earnings calls (UMAC)
Financials
What the filings say
Net profit, year on year: −12% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 2 | 2 | 2 | 2 | 2 | 5 | 8 | 17 |
| Operating profit | -1 | -13 | -3 | -7 | -5 | -10 | -7 | -8 |
| Operating margin | −95.4% | −642.3% | −160.0% | −338.5% | −232.4% | −198.7% | −89.7% | −46.9% |
| Other income | -1 | -14 | 0 | 0 | 7 | -1 | 18 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | — | — | -3 | — | — | — | 10 | — |
| Tax rate | — | — | 0.0% | — | — | — | 0.0% | — |
| Net profit | -2 | -27 | -3 | -7 | 2 | -11 | 10 | -8 |
| EPS ($ per share) | -0.30 | — | -0.21 | -0.32 | 0.05 | — | 0.22 | -0.16 |
| Line item | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 |
| Reserves | -2 | -4 | -36 | -55 |
| Total liabilities | 0 | 0 | 1 | 8 |
| Fixed assets | 0 | 0 | 0 | 2 |
| Investments | — | — | 0 | 39 |
| Total assets | 3 | 2 | 16 | 183 |
| Line item | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Cash from operations | -1 | -2 | -4 | -21 |
| Cash from investing | 0 | -0 | -1 | -37 |
| Cash from financing | 0 | -0 | 8 | 158 |
| Capital expenditure | -0 | -0 | 0 | -2 |
| Free cash flow | -1 | -2 | -4 | -23 |
Insider filings
41 filings between Nov 20, 2025 and Aug 20, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$11.01M
22 sales by 7 insiders
68% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 16
- Award — granted as compensation
- 3
- Option exercise — converted options into shares
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Hoff Brian Joseph | — | $4.18M | Aug 20, 2026 |
| Camden Andrew Ross | — | $4.17M | Aug 20, 2026 |
| Wright Stacy Rochelle | — | $970.3K | Aug 20, 2026 |
| Thompson Jeffrey M | — | $815.7K | Jun 8, 2026 |
| Rich Sanford | — | $786.1K | Jun 1, 2026 |
| Colon Cristina | — | $74.9K | Nov 20, 2025 |
| Evans Allan Thomas | — | $22.1K | Dec 29, 2025 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Aug 20, 2026 | Wright Stacy Rochelle Chief Revenue Officer | Sale 10b5-1 plan | 27,500 | $715.0K |
| Aug 20, 2026 | Camden Andrew Ross President | Sale 10b5-1 plan | 9,625 | $250.3K |
| Aug 20, 2026 | Hoff Brian Joseph Chief Financial Officer | Sale 10b5-1 plan | 11,413 | $296.8K |
| Jun 8, 2026 | Thompson Jeffrey M Director | Sale | 15,000 | $411.3K |
| Jun 5, 2026 | Thompson Jeffrey M Director | Sale | 15,000 | $404.4K |
| Jun 4, 2026 | Camden Andrew Ross President | Sale | 100,000 | $3.00M |
| Jun 1, 2026 | Rich Sanford Director | Sale 10b5-1 plan | 25,000 | $724.5K |
| May 27, 2026 | Hoff Brian Joseph Chief Financial Officer | Sale 10b5-1 plan | 150,000 | $2.66M |
| May 21, 2026 | Rich Sanford Director | Sale 10b5-1 plan | 1,392 | $19.7K |
| May 21, 2026 | Hoff Brian Joseph Chief Financial Officer | Sale 10b5-1 plan | 11,412 | $161.7K |
| May 21, 2026 | Camden Andrew Ross President | Sale 10b5-1 plan | 9,625 | $136.4K |
| May 20, 2026 | Rich Sanford Director | Award 10b5-1 plan | 2,784 | $0 |
| May 20, 2026 | Lowry Robert Paul Director | Award | 2,784 | $0 |
| May 20, 2026 | Thompson Jeffrey M Director | Award | 2,784 | $0 |
| Mar 16, 2026 | Camden Andrew Ross President | Sale 10b5-1 plan | 9,625 | $178.8K |
| Mar 16, 2026 | Rich Sanford Director | Sale 10b5-1 plan | 980 | $19.8K |
| Mar 16, 2026 | Hoff Brian Joseph Chief Financial Officer | Sale 10b5-1 plan | 11,413 | $212.2K |
| Mar 16, 2026 | Wright Stacy Rochelle Chief Revenue Officer | Sale 10b5-1 plan | 13,750 | $255.3K |
| Mar 13, 2026 | Rich Sanford Director | Award 10b5-1 plan | 1,961 | $0 |
| Mar 13, 2026 | Thompson Jeffrey M Director | Award | 1,961 | $0 |
| Mar 13, 2026 | Lowry Robert Paul Director | Award | 1,961 | $0 |
| Jan 23, 2026 | Wright Stacy Rochelle Chief Revenue Officer | Award | 110,000 | $0 |
| Jan 23, 2026 | Evans Allan Thomas Chief Executive Officer | Award | 220,000 | $0 |
| Jan 23, 2026 | Hoff Brian Joseph Chief Financial Officer | Award | 110,000 | $0 |
| Jan 23, 2026 | Camden Andrew Ross President | Award | 110,000 | $0 |
| Dec 31, 2025 | Lowry Robert Paul Director | Award | 3,140 | $0 |
| Dec 31, 2025 | Thompson Jeffrey M Director | Award | 3,140 | $0 |
| Dec 31, 2025 | Colon Cristina Director | Award | 3,140 | $0 |
| Dec 29, 2025 | Rich Sanford Director | Sale | 11,087 | $22.1K |
| Dec 29, 2025 | Lowry Robert Paul Director | Option exercise | 32,895 | $65.5K |
| Dec 29, 2025 | Evans Allan Thomas Chief Executive Officer | Option exercise | 65,789 | $130.9K |
| Dec 29, 2025 | Evans Allan Thomas Chief Executive Officer | Sale | 11,087 | $22.1K |
| Dec 29, 2025 | Rich Sanford Director | Option exercise | 65,789 | $130.9K |
| Dec 12, 2025 | Camden Andrew Ross Chief Operating Officer | Sale | 50,000 | $515.8K |
| Dec 12, 2025 | Hoff Brian Joseph Chief Financial Officer | Sale | 75,000 | $773.6K |
| Nov 20, 2025 | Evans Allan Thomas Chief Executive Officer | Award | 250,000 | $0 |
| Nov 20, 2025 | Hoff Brian Joseph Chief Financial Officer | Award 10b5-1 plan | 125,000 | $0 |
| Nov 20, 2025 | Hoff Brian Joseph Chief Financial Officer | Sale 10b5-1 plan | 8,750 | $79.6K |
| Nov 20, 2025 | Colon Cristina Director | Sale 10b5-1 plan | 8,268 | $74.9K |
| Nov 20, 2025 | Camden Andrew Ross Chief Operating Officer | Award 10b5-1 plan | 125,000 | $0 |
| Nov 20, 2025 | Camden Andrew Ross Chief Operating Officer | Sale 10b5-1 plan | 8,750 | $79.6K |
| Aug 21, 2025 | Hoff Brian Joseph Chief Financial Officer | Sale 10b5-1 plan | 33,750 | $344.5K |
| Aug 21, 2025 | Camden Andrew Ross Chief Operating Officer | Sale 10b5-1 plan | 35,000 | $357.3K |
| Aug 20, 2025 | Hoff Brian Joseph Chief Financial Officer | Sale 10b5-1 plan | 8,750 | $85.8K |
| Aug 20, 2025 | Camden Andrew Ross Chief Operating Officer | Sale 10b5-1 plan | 8,750 | $85.8K |
| Aug 19, 2025 | Lowry Robert Paul Director | Award | 2,308 | $0 |
| Aug 19, 2025 | Thompson Jeffrey M Director | Award | 2,308 | $0 |
| Aug 19, 2025 | Colon Cristina Director | Award | 2,308 | $0 |
| Aug 19, 2025 | Rich Sanford Director | Award | 2,308 | $0 |
| Jun 30, 2025 | Evans Allan Thomas Chief Executive Officer | Award | 175,000 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Unusual Machines, Inc.
Free account. Everything above stays public.
Write why you follow Unusual Machines, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading